Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website (MIBS trial)
Background: IBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affect quality of life, social functioning and time off work. Current GP treatment relies on a positive diagnosis, reassurance,lifestyle advice and drug therapies, but many suffer ongoing symptoms....
Main Authors: | Everitt, Hazel A. (Author), Moss-Morris, Rona E. (Author), Sibelli, Alice (Author), Tapp, Laura (Author), Coleman, Nicholas S. (Author), Yardley, Lucy (Author), Smith, Peter W. (Author), Little, Paul S. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2010.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)
by: Yardley Lucy, et al.
Published: (2010-11-01) -
Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website
by: Everitt, Hazel, et al.
Published: (2013) -
Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial
by: Zahra Pourmoghaddas, et al.
Published: (2014-01-01) -
Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial
by: Z Pourmoghaddas, et al.
Published: (2014-04-01) -
Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
by: Dwaipayan Sarathi Chakraborty, et al.
Published: (2019-01-01)